Efficacy of Semaglutide in Treating Obesity: A Systematic Review of Randomized Controlled Trials (RCTs)
Author:
Publisher
Cureus, Inc.
Subject
Aerospace Engineering
Reference28 articles.
1. Obesity and cardiovascular disease: a scientific statement from the American Heart Association;Powell-Wiley TM;Circulation,2021
2. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society;Jensen MD;Circulation,2014
3. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin;Knowler WC;N Engl J Med,2002
4. Long-term effects of weight-reducing drugs in people with hypertension;Siebenhofer A;Cochr Datab Syst Rev,2016
5. The obesity syndrome and acanthosis nigricans. Acanthosis nigricans is a common cosmetic problem providing epidemiological clues to the obesity syndrome, the insulin-resistance syndrome, the thrifty metabolism, dyslipidaemia, hypertension and diabetes mellitus type II;Maitra SK;J Cosmet Dermatol,2004
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The crucial role of beta-catenin in the osteoprotective effect of semaglutide in an ovariectomized rat model of osteoporosis;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-09-10
2. Effect of Semaglutide in Individuals With Obesity or Overweight Without Diabetes;Cureus;2024-08-27
3. Efficacy and safety of once‐weekly subcutaneous semaglutide on weight loss in patients with overweight or obesity without diabetes mellitus—A systematic review and meta‐analysis of randomized controlled trials;Obesity Reviews;2024-06-23
4. The role of nanosystems in the delivery of glucose-lowering drugs for the preemption and treatment of diabetes-associated atherosclerosis;American Journal of Physiology-Cell Physiology;2024-05-01
5. Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer: A Narrative Review;Thyroid®;2024-03-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3